Public Sector Pension Investment Board Has $2.74 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Public Sector Pension Investment Board lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 1.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,729 shares of the company’s stock after selling 100 shares during the quarter. Public Sector Pension Investment Board’s holdings in HCA Healthcare were worth $2,735,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of HCA. Cetera Investment Advisers boosted its holdings in HCA Healthcare by 205.2% during the 1st quarter. Cetera Investment Advisers now owns 18,753 shares of the company’s stock worth $6,255,000 after acquiring an additional 12,608 shares during the last quarter. Mather Group LLC. raised its stake in shares of HCA Healthcare by 7.2% during the 2nd quarter. Mather Group LLC. now owns 867 shares of the company’s stock worth $289,000 after purchasing an additional 58 shares during the period. CWM LLC raised its stake in HCA Healthcare by 10.5% in the 2nd quarter. CWM LLC now owns 9,867 shares of the company’s stock valued at $3,170,000 after acquiring an additional 937 shares during the period. CX Institutional raised its stake in HCA Healthcare by 13.1% in the 2nd quarter. CX Institutional now owns 2,090 shares of the company’s stock valued at $672,000 after acquiring an additional 242 shares during the period. Finally, BDF Gestion bought a new stake in shares of HCA Healthcare during the second quarter valued at about $3,853,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $324.09 on Thursday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a fifty-two week low of $251.55 and a fifty-two week high of $417.14. The stock has a 50 day moving average price of $367.20 and a two-hundred day moving average price of $358.65. The company has a market capitalization of $82.09 billion, a P/E ratio of 14.55, a PEG ratio of 1.26 and a beta of 1.63.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.81%. HCA Healthcare’s payout ratio is currently 11.85%.

Wall Street Analysts Forecast Growth

HCA has been the topic of several analyst reports. TD Cowen decreased their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Truist Financial upped their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. KeyCorp cut their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. Finally, Barclays cut their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $380.29.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,155 shares of company stock worth $5,608,990. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.